CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 806 of 865
Non-Antibody Products
Page 806 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Tiplaxtinin | A PAI-1 inhibitor (IC50 = 2.7 µM for the human enzyme); inhibits dif… | 1 mg | 9000450-1 | More Info |
| Tiplaxtinin | A PAI-1 inhibitor (IC50 = 2.7 µM for the human enzyme); inhibits dif… | 10 mg | 9000450-10 | More Info |
| Tiplaxtinin | A PAI-1 inhibitor (IC50 = 2.7 µM for the human enzyme); inhibits dif… | 5 mg | 9000450-5 | More Info |
| Tiplaxtinin | A PAI-1 inhibitor (IC50 = 2.7 µM for the human enzyme); inhibits dif… | 50 mg | 9000450-50 | More Info |
| Tipranavir | A nonpeptidic HIV aspartyl protease inhibitor (Ki = < 1 nM) | 1 mg | 21028-1 | More Info |
| Tipranavir | A nonpeptidic HIV aspartyl protease inhibitor (Ki = < 1 nM) | 5 mg | 21028-5 | More Info |
| Tipranavir-d4 | An internal standard for the quantification of tipranavir by GC- or LC-MS | 1 mg | 28907-1 | More Info |
| TIQ-A | A PARP1 inhibitor (IC50 = 450 nM) that displays neuroprotective effects in… | 1 mg | 16112-1 | More Info |
| TIQ-A | A PARP1 inhibitor (IC50 = 450 nM) that displays neuroprotective effects in… | 10 mg | 16112-10 | More Info |
| TIQ-A | A PARP1 inhibitor (IC50 = 450 nM) that displays neuroprotective effects in… | 5 mg | 16112-5 | More Info |
| TIQ-A | A PARP1 inhibitor (IC50 = 450 nM) that displays neuroprotective effects in… | 500 µg | 16112-500 | More Info |
| Tirapazamine | A hypoxia-activated anticancer agent; is converted to an oxidizing radical… | 10 mg | 25981-10 | More Info |
| Tirapazamine | A hypoxia-activated anticancer agent; is converted to an oxidizing radical… | 100 mg | 25981-100 | More Info |
| Tirapazamine | A hypoxia-activated anticancer agent; is converted to an oxidizing radical… | 250 mg | 25981-250 | More Info |
| Tirapazamine | A hypoxia-activated anticancer agent; is converted to an oxidizing radical… | 50 mg | 25981-50 | More Info |
| Tirasemtiv | An activator of the fast skeletal troponin complex; selectively binds to p… | 10 mg | 26075-10 | More Info |
| Tirasemtiv | An activator of the fast skeletal troponin complex; selectively binds to p… | 25 mg | 26075-25 | More Info |
| Tirasemtiv | An activator of the fast skeletal troponin complex; selectively binds to p… | 5 mg | 26075-5 | More Info |
| Tirasemtiv | An activator of the fast skeletal troponin complex; selectively binds to p… | 50 mg | 26075-50 | More Info |
| Tiratricol | A thyroid hormone receptor agonist (EC50s = 1.81 and 4.13 nM for TRα… | 1 g | 28729-1 | More Info |
| Tiratricol | A thyroid hormone receptor agonist (EC50s = 1.81 and 4.13 nM for TRα… | 100 mg | 28729-100 | More Info |
| Tiratricol | A thyroid hormone receptor agonist (EC50s = 1.81 and 4.13 nM for TRα… | 50 mg | 28729-50 | More Info |
| Tiratricol | A thyroid hormone receptor agonist (EC50s = 1.81 and 4.13 nM for TRα… | 500 mg | 28729-500 | More Info |
| Tirofiban (hydrochloride hydrate) | A GPIIb / IIIa antagonist (IC50 = 5 nM in a radioligand binding assay); in… | 1 mg | 23392-1 | More Info |
| Tirofiban (hydrochloride hydrate) | A GPIIb / IIIa antagonist (IC50 = 5 nM in a radioligand binding assay); in… | 10 mg | 23392-10 | More Info |
| Tirofiban (hydrochloride hydrate) | A GPIIb / IIIa antagonist (IC50 = 5 nM in a radioligand binding assay); in… | 5 mg | 23392-5 | More Info |
| Tirucallol | A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory… | 1 mg | 35623-1 | More Info |
| Tirucallol | A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory… | 5 mg | 35623-5 | More Info |
| Tirucallol | A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory… | 500 µg | 35623-500 | More Info |
| Tirzepatide (sodium salt) | A dual GLP-1R and GPR119 agonist; induces cAMP production in HEK293 cells… | 1 mg | 39748-1 | More Info |
| Tirzepatide (sodium salt) | A dual GLP-1R and GPR119 agonist; induces cAMP production in HEK293 cells… | 10 mg | 39748-10 | More Info |
| Tirzepatide (sodium salt) | A dual GLP-1R and GPR119 agonist; induces cAMP production in HEK293 cells… | 25 mg | 39748-25 | More Info |
| Tirzepatide (sodium salt) | A dual GLP-1R and GPR119 agonist; induces cAMP production in HEK293 cells… | 5 mg | 39748-5 | More Info |
| Tivantinib | An inhibitor of c-Met (Ki = 0.355 µM); selective for c-Met over a pa… | 1 mg | 17135-1 | More Info |
| Tivantinib | An inhibitor of c-Met (Ki = 0.355 µM); selective for c-Met over a pa… | 10 mg | 17135-10 | More Info |
| Tivantinib | An inhibitor of c-Met (Ki = 0.355 µM); selective for c-Met over a pa… | 5 mg | 17135-5 | More Info |
| Tivozanib (hydrate) | An orally available, selective VEGFR inhibitor (IC50s = 0.21, 0.16, and 0.… | 1 mg | 18493-1 | More Info |
| Tivozanib (hydrate) | An orally available, selective VEGFR inhibitor (IC50s = 0.21, 0.16, and 0.… | 10 mg | 18493-10 | More Info |
| Tivozanib (hydrate) | An orally available, selective VEGFR inhibitor (IC50s = 0.21, 0.16, and 0.… | 5 mg | 18493-5 | More Info |
| Tizanidine-d4 (hydrochloride) | An internal standard for the quantification of tizanidine by GC- or LC-MS | 1 mg | 26521-1 | More Info |
| Tizanidine-d4 (hydrochloride) | An internal standard for the quantification of tizanidine by GC- or LC-MS | 500 µg | 26521-500 | More Info |
| Tizanidine (hydrochloride) | An α2-adrenergic receptor agonist (α2-AR); reduces neuronal ex… | 10 mg | 16477-10 | More Info |
| Tizanidine (hydrochloride) | An α2-adrenergic receptor agonist (α2-AR); reduces neuronal ex… | 25 mg | 16477-25 | More Info |
| Tizanidine (hydrochloride) | An α2-adrenergic receptor agonist (α2-AR); reduces neuronal ex… | 50 mg | 16477-50 | More Info |
| Tizanidine (hydrochloride) | An α2-adrenergic receptor agonist (α2-AR); reduces neuronal ex… | 500 mg | 16477-500 | More Info |
| Tizanidine (hydrochloride) | An analytical reference standard categorized as a muscle relaxant; inhibit… | 1 mg | 38559-1 | More Info |
| Tizanidine (hydrochloride) | An analytical reference standard categorized as a muscle relaxant; inhibit… | 5 mg | 38559-5 | More Info |
| Tizoxanide | An active metabolite of nitazoxanide; active against M. tuberculosis (MIC… | 1 mg | 13693-1 | More Info |
| Tizoxanide | An active metabolite of nitazoxanide; active against M. tuberculosis (MIC… | 10 mg | 13693-10 | More Info |
| Tizoxanide | An active metabolite of nitazoxanide; active against M. tuberculosis (MIC… | 25 mg | 13693-25 | More Info |
| Tizoxanide | An active metabolite of nitazoxanide; active against M. tuberculosis (MIC… | 5 mg | 13693-5 | More Info |
| Tizoxanide-d4 | An internal standard for the quantification of tizoxanide by GC- or LC-MS | 1 mg | 28533-1 | More Info |
| TK05 | An LTC4 synthase inhibitor (IC50 = 95 nM); selective for LTC4 synthase ove… | 1 mg | 19793-1 | More Info |
| TK05 | An LTC4 synthase inhibitor (IC50 = 95 nM); selective for LTC4 synthase ove… | 250 µg | 19793-250 | More Info |
| TK05 | An LTC4 synthase inhibitor (IC50 = 95 nM); selective for LTC4 synthase ove… | 500 µg | 19793-500 | More Info |
| TLR7 Agonist 2 | A TLR7 agonist (LEC = 0.4 µM in a cell-based reporter assay); select… | 1 mg | 28450-1 | More Info |
| TLR7 Agonist 2 | A TLR7 agonist (LEC = 0.4 µM in a cell-based reporter assay); select… | 10 mg | 28450-10 | More Info |
| TLR7 Agonist 2 | A TLR7 agonist (LEC = 0.4 µM in a cell-based reporter assay); select… | 5 mg | 28450-5 | More Info |
| TLR7/8 Agonist 1 (hydrochloride) | A dual agonist of TLR7 and TLR8 (EC50s = 50 and 55 nM, respectively, in ce… | 1 mg | 28451-1 | More Info |
| TLR7/8 Agonist 1 (hydrochloride) | A dual agonist of TLR7 and TLR8 (EC50s = 50 and 55 nM, respectively, in ce… | 5 mg | 28451-5 | More Info |
| TLR7/8 Agonist 1 (hydrochloride) | A dual agonist of TLR7 and TLR8 (EC50s = 50 and 55 nM, respectively, in ce… | 500 µg | 28451-500 | More Info |
| TLR4-C34 | A 2-acetamidopyranoside that selectively inhibits TLR4 signaling in entero… | 10 mg | 18512-10 | More Info |
| TLR4-C34 | A 2-acetamidopyranoside that selectively inhibits TLR4 signaling in entero… | 25 mg | 18512-25 | More Info |
| TLR4-C34 | A 2-acetamidopyranoside that selectively inhibits TLR4 signaling in entero… | 5 mg | 18512-5 | More Info |
| TLR4-C34 | A 2-acetamidopyranoside that selectively inhibits TLR4 signaling in entero… | 50 mg | 18512-50 | More Info |
| 1T-LSD (solution) | An analytical reference standard categorized as a lysergamide; has been fo… | 100 µg | 40712-100 | More Info |
| TM5275 | A PAI-1 inhibitor (IC50 = 6.95 µM); inhibits formation of a complex… | 1 mg | 23151-1 | More Info |
| TM5275 | A PAI-1 inhibitor (IC50 = 6.95 µM); inhibits formation of a complex… | 10 mg | 23151-10 | More Info |
| TM5275 | A PAI-1 inhibitor (IC50 = 6.95 µM); inhibits formation of a complex… | 25 mg | 23151-25 | More Info |
| TM5275 | A PAI-1 inhibitor (IC50 = 6.95 µM); inhibits formation of a complex… | 5 mg | 23151-5 | More Info |
| TM5441 | A PAI-1 inhibitor; decreases survival of HT1080, HCT116, Daoy, MDA-MB-231,… | 1 mg | 22965-1 | More Info |
| TM5441 | A PAI-1 inhibitor; decreases survival of HT1080, HCT116, Daoy, MDA-MB-231,… | 10 mg | 22965-10 | More Info |
| TM5441 | A PAI-1 inhibitor; decreases survival of HT1080, HCT116, Daoy, MDA-MB-231,… | 5 mg | 22965-5 | More Info |
| TMA-DPH | A fluorescent probe used for measuring membrane fluidity in artificial and… | 1 mg | 17294-1 | More Info |
| TMA-DPH | A fluorescent probe used for measuring membrane fluidity in artificial and… | 5 mg | 17294-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile